HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

P&G Targets $10 Billion In Cost Savings In Four Years

This article was originally published in The Tan Sheet

Executive Summary

P&G targets $10 billion in cost cuts before October 2016, including cutting $4.5 billion in spending on raw and packaging materials for its products and reducing overhead by $3 billion. The firm also plans to cut 5,700 jobs within 18 months.

You may also be interested in...



Rising Material Costs Burden P&G's Earnings, Spark Price Increases

The marketer of Crest and Prilosec OTC takes a $1.5 billion write-down on its appliances business, and faces continuing pressure from commodity costs. The health care segment’s net sales increased 1% to $3.2 billion, but price increases added 3% to the total, the firm said.

Verona Details COPD Opportunity For Ensifentrine

Verona Pharma’s candidate COPD therapy ensifentrine has a first-in-class dual mechanism of action and is to be explored as an add-on to LAMA and LABA therapy in two Phase III clinical studies.

Warning Letter Roundup & Recap – 2 June 2020

No device-related warning letters were released by the US FDA the week of 2 June.

Topics

Related Companies

UsernamePublicRestriction

Register

SC142321

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel